Literature DB >> 30535004

Direct activation of G-protein-gated inward rectifying K+ channels promotes nonrapid eye movement sleep.

Bende Zou1, William S Cao1, Zhiwei Guan2, Kui Xiao1, Conrado Pascual1, Julian Xie1, Jingxi Zhang1, James Xie1, Frank Kayser1, Craig W Lindsley3, C David Weaver3, Jidong Fang2, Xinmin Simon Xie1.   

Abstract

STUDY
OBJECTIVES: A major challenge in treating insomnia is to find effective medicines with fewer side effects. Activation of G-protein-gated inward rectifying K+ channels (GIRKs) by GABAB agonists baclofen or γ-hydroxybutyric acid (GHB) promotes nonrapid eye movement (NREM) sleep and consolidates sleep. However, baclofen has poor brain penetration, GHB possesses abuse liability, and in rodents both drugs cause spike-wave discharges (SWDs), an absence seizure activity. We tested the hypothesis that direct GIRK activation promotes sleep without inducing SWD using ML297, a potent and selective GIRK activator.
METHODS: Whole-cell patch-clamp recordings from hypocretin/orexin or hippocampal neurons in mouse brain slices were made to study neuronal excitability and synaptic activity; spontaneous activity, locomotion, contextual and tone-conditioned memory, and novel object recognition were assessed. Electroencephalogram/electromyogram (EEG/EMG) recordings were used to study GIRK modulation of sleep.
RESULTS: ML297, like baclofen, caused membrane hyperpolarization, decreased input resistance, and blockade of spontaneous action potentials. Unlike baclofen, ML297 (5-10 µM) did not cause significant depression of postsynaptic excitatory and inhibitory currents (EPSCs-IPSCs), indicating preferential postsynaptic inhibition. ML297 (30 mg/kg, i.p.) inhibited wake activity and locomotion, and preferentially increased NREM sleep without altering EEG delta power, REM sleep, inducing SWDs, or impairing conditioned memory and novel object recognition.
CONCLUSIONS: This study finds that direct activation of neuronal GIRK channels modulates postsynaptic membrane excitability and prolongs NREM sleep without changing sleep intensity, inducing SWDs, or impairing memory in rodents. These results suggest that direct GIRK activation with a selective compound may present an innovative approach for the treatment of chronic insomnia. © Sleep Research Society 2018. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.

Entities:  

Keywords:  G-protein-gated inwardly rectifying potassium channels; ML297; hippocampus; hypothalamus; patch clamp recording; sleep

Mesh:

Substances:

Year:  2019        PMID: 30535004      PMCID: PMC6424090          DOI: 10.1093/sleep/zsy244

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  56 in total

1.  Mice lacking the TNF 55 kDa receptor fail to sleep more after TNFalpha treatment.

Authors:  J Fang; Y Wang; J M Krueger
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

2.  Pre-synaptic GABA receptors inhibit glutamate release through GIRK channels in rat cerebral cortex.

Authors:  Carolina Ladera; María del Carmen Godino; María José Cabañero; Magdalena Torres; Masahiko Watanabe; Rafael Luján; José Sánchez-Prieto
Journal:  J Neurochem       Date:  2008-12       Impact factor: 5.372

3.  Reversal of the sleep-wake cycle by heroin self-administration in rats.

Authors:  Alissa A Coffey; Zhiwei Guan; Patricia S Grigson; Jidong Fang
Journal:  Brain Res Bull       Date:  2015-09-30       Impact factor: 4.077

4.  Voluntary wheel-running attenuates insulin and weight gain and affects anxiety-like behaviors in C57BL6/J mice exposed to a high-fat diet.

Authors:  Jasmin A Hicks; Aikaterini Hatzidis; Nicole L Arruda; Rachel R Gelineau; Isabella Monteiro De Pina; Kenneth W Adams; Joseph A Seggio
Journal:  Behav Brain Res       Date:  2016-05-03       Impact factor: 3.332

Review 5.  Sleep disturbances, TBI and PTSD: Implications for treatment and recovery.

Authors:  Karina Stavitsky Gilbert; Sarah M Kark; Philip Gehrman; Yelena Bogdanova
Journal:  Clin Psychol Rev       Date:  2015-06-03

6.  GABAB agonism promotes sleep and reduces cataplexy in murine narcolepsy.

Authors:  Sarah Wurts Black; Stephen R Morairty; Tsui-Ming Chen; Andrew K Leung; Jonathan P Wisor; Akihiro Yamanaka; Thomas S Kilduff
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

7.  gamma-Hydroxybutyrate depresses monosynaptic excitatory and inhibitory postsynaptic potentials in rat hippocampal slices.

Authors:  X Xie; T G Smart
Journal:  Eur J Pharmacol       Date:  1992-11-17       Impact factor: 4.432

8.  GIRK2 splice variants and neuronal G protein-gated K+ channels: implications for channel function and behavior.

Authors:  Ezequiel Marron Fernandez de Velasco; Lei Zhang; Baovi N Vo; Megan Tipps; Shannon Farris; Zhilian Xia; Allison Anderson; Nicholas Carlblom; C David Weaver; Serena M Dudek; Kevin Wickman
Journal:  Sci Rep       Date:  2017-05-09       Impact factor: 4.379

Review 9.  Kir3 channel signaling complexes: focus on opioid receptor signaling.

Authors:  Karim Nagi; Graciela Pineyro
Journal:  Front Cell Neurosci       Date:  2014-07-08       Impact factor: 5.505

10.  Automated monitoring of early neurobehavioral changes in mice following traumatic brain injury.

Authors:  Wenrui Qu; Nai-Kui Liu; Xin-Min Simon Xie; Rui Li; Xiao-Ming Xu
Journal:  Neural Regen Res       Date:  2016-02       Impact factor: 5.135

View more
  3 in total

Review 1.  Neuronal G protein-gated K+ channels.

Authors:  Haichang Luo; Ezequiel Marron Fernandez de Velasco; Kevin Wickman
Journal:  Am J Physiol Cell Physiol       Date:  2022-06-15       Impact factor: 5.282

Review 2.  Advances in Targeting GIRK Channels in Disease.

Authors:  Yulin Zhao; Isabel Gameiro-Ros; Ian W Glaaser; Paul A Slesinger
Journal:  Trends Pharmacol Sci       Date:  2021-01-16       Impact factor: 14.819

Review 3.  Next-generation inward rectifier potassium channel modulators: discovery and molecular pharmacology.

Authors:  C David Weaver; Jerod S Denton
Journal:  Am J Physiol Cell Physiol       Date:  2021-04-07       Impact factor: 5.282

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.